Not registered yet? Please contact our project manager Dr. Sara Stöber . This area is only for members of the research consortium.

Recent developments, awards & more

To receive our project newsletter please subscribe here!

News

  • French translation of QSPainRelief info brochure ready for the WP8 clinical trial

    30 July 2021

    You can now access a web and a print version of the project’s info brochure translated into French on the DOWNLOADS or TÉLÉCHARGEMENTS page, respectively. Thanks a bunch for the help of the team at UCL in providing the translations. We hope the brochure will be well-received by pain patients participating in the clinical trial of WP8, which is starting soon!

  • QSPainRelief Masterclass by Prof. Rafael Maldonado now online

    21 July 2021

    Watch our 2nd Masterclass on “Evaluating reward, drug abuse & addiction” held by the leader of work package 6 (WP6), Prof. Dr. Rafael Maldonado from UPF, an expert on preclinical research regarding nociception, pain medication, and the development of addiction. Learn about operant self-administration of opioids (or any other potential “drug”, including alcohol or food) in animal models of reward, reinforcement, abuse liability, and addiction.

  • Thank you, Joop!

    20 July 2021

    A big thank you to Joop van Griensven for his excellent service on QSPainRelief’s Scientific and Ethical Advisory Board (SEAB) and congratulations to receiving the well-deserved “Lifetime Achievement Award” from the EFNA Advocacy Awards. We are quite sad to see him leave as president of Pain Alliance Europe (PAE), but wish him all the best, and are looking forward to collaborate with his successor, Deirdre Ryan!

    Read More
  • Successful 4th Steering Committee (SC) Meeting

    13-13 July 2021

    The 4th QSPainRelief Steering Committee (SC) Meeting took place from 13-14 July 2021 via Zoom. Highlights of the meeting were the progress made in developing the QSPainRelief model platform (WP2) and the readiness for patient recruitment in the clinical study at UCL (WP8). Looking forward to the next meeting, hopefully in person again!

  • Open position – PhD student (UNIBO)

    23 April 2021

    Apply until 21 May 2021: In the frame of the PhD program in Biotechnological, Biocomputational, Pharmaceutical and Pharmacological Sciences (B2F2), the Department of Pharmacy and Biotechnology (FaBiT) at UNIBO is looking for a PhD student as part of QSPainRelief! The selected applicant will join the Molecular and Cellular Pharmacology Unit to investigate gene expression and cellular signaling and to perform molecular pathway analysis in rat and mouse primary cultures from distinct brain regions as well as in human neuronal cell lines. This is aiming at developing and implementing an innovative Quantitative Systems Pharmacology platform for the identification of more effective and safer combinational treatments of chronic pain. If interested, please contact Dr. Andrea Bedini. For further information about the selection process, call for application, deadlines, and the admission board, click here.

    More information about the B2F2 department!

  • QSPainRelief Masterclass by Prof. Albert Dahan now online

    01 March 2021

    This is the first QSPainRelief Masterclass, held by our scientific and ethical advisory board (SEAB) member Prof. Dr. Albert Dahan from Leiden University Medical Center (LUMC) in Leiden, The Netherlands, during the project’s 2nd General Assembly (GA) Meeting on December 10th, 2020. As an expert on chronic pain treatment, he provides detailed insight on the current approaches used in the clinical treatment of chronic pain patients.

    Read More
  • 2nd GA Meeting in December 2020

    09-10 December 2020

    Originally planned in Cologne, the 2nd QSPainRelief General Assembly (GA) Meeting meeting took place from 09-10 December 2020 via Zoom. Please refer to Twitter and LinkedIn for updates form the meeting itself. We were also excited to have the SEAB members present and to hear about the first research results of our early-career scientists (ECS)!

  • First publication of the project by Jesús Giraldo

    17 November 2020

    The first QSPainRelief publication on the statistics of molecular dynamics simulations is out! Congrats to Prof. Jesús Giraldo and colleagues from Institut de Neurociències (INc) at the Universitat Autònoma de Barcelona (UAB) on this achievement!

    Read More
  • Prof. Liesbeth de Lange wins lifetime career award!

    13 November 2020

    Congrats to “the Ferrari of pharmacology”, our scientific coordinator, Prof. Liesbeth de Lange, who just won the “Lewis B. Sheiner Lifetime Achievement Award” from the International Society of Pharmacometrics (ISoP)! Read more.

  • The QSPainRelief info brochure is available!

    22 September 2020

    Click on the image below to access the web version of the project’s info folder and to download it!

  • Project video & successful 1st patient event at PAE’s annual GA Meeting!

    25 June 2020

    QSPainRelief’s first patient event took place as part of Pain Alliance Europe’s (PAE) annual General Assembly (GA) Meeting this year: Our project’s scientific coordinator, Prof. Dr. Liesbeth de Lange, presented the scope of the project in a 20-min lecture on Wednesday, 24 June 2020. The talk was well-received by the audience of 23 laymen and representatives of European pain patient organisations from 19 different countries. Click below to watch the lecture video on YouTube!

  • 2nd SC Meeting concluded

    23-24 June 2020

    The 2nd QSPainRelief Steering Committee (SC) Meeting took place on Tuesday & Wednesday, 23-24 June 2020, remotely via GoToMeeting due to the corona crisis. The progress of each work package was presented, upcoming tasks and issues around COVID-19 were discussed, and the data and safety monitoring committee (DSMC) was elected. Despite the unforeseeable challenges, such as closed laboratories and home office, the project is advancing well, especially the in silico modelling.

  • QSPainRelief first patient event: At 2:30 pm this Wednesday, Prof. Liesbeth de Lange speaks at PAE’s Annual Meeting!

    22 June 2020

    QSPainRelief’s first patient event will take place as part of Pain Alliance Europe’s (PAE) annual meeting this Wednesday. Our project’s scientific coordinator, Prof. Dr. Liesbeth de Lange, will present the scope of the project in a 30-min presentation at 2:30 pm on Wednesday, 24 June 2020! If you are a PAE member joining the event, we look forward to meeting you during Liesbeth’s talk and hear your feedback and questions regarding our research. We also hope you will help us make QSPainRelief known in your local and online patient community!

  • Dissemination & Communication Plan ready

    25 March 2020

    ULEI, ISB, and concentris have developed the “Dissemination & Communication Plan” (D9.1), a confidential 40+ page important document for the entire consortium that identifies key stakeholders, and outlines a detailed strategy as well as tasks, responsibilities and target release dates for internal communication, dissemination towards target groups, training activities, exploitation, and protection of intellectual property rights (IPR) for the duration of the project. D9.1 is available for download from the intranet for all project partners and SEAB members.

    Download here
  • Honorary Doctorate for Liesbeth de Lange – congrats!

    05 February 2020

    Professor Elizabeth de Lange was honoured on 31 January 2020 by the University of Uppsala, which appointed her Honorary Doctor at the end of 2019. During the ceremony, De Lange received all three symbols of honour for an Honorary Doctorate: a hat, a diploma, and a ring. ‘An incredibly wonderful experience!’ and ‘Wherever possible, I work with Uppsala and will continue to do so. Uppsala has become a second home to me.’ Liesbeth says about the ceremony and her Swedish colleagues.

  • Successful Kick-off Meeting in Leiden!

    24 January 2020

    QSPainRelief successfully kicked off in Leiden, The Netherlands, from 22-24 January 2020. Consortium members outlined the work ahead over the next 12 months, made first decisions, and incorporated valuable feedback from the scientific and ethics advisory board.

  • The QSPainRelief project starts today!

    01 January 2020

    Today, the 5-year long, pan-European research project begins. All of us are excited to roll up our sleeves and get to work! A total of 10 QSPainRelief work packages (WPs) will cover the entire value chain of research and development, from discovery to market preparation.